UnknownNCT03972735
Official study titleRandomized Controlled Study on the Efficacy of the NECT Program (Cognitive Therapy and Narrative Development) on Improving Social Functioning in People With Severe Psychic Disorders
Current recruitment status is unconfirmed.
Multiple locations, including AnnecyPersonality disorders, Schizophrenia, ...Placebo comparisonAges 18–60
- Countries
- France, Switzerland
- Sponsor
- Hospital Center Alpes-Isère
CompletedNCT01931644
Official study titleA Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
This study has finished and is no longer accepting participants.
In Los AngelesADHD, Bipolarity, ...Observational studyAges 18–100
- Countries
- United States
- Sponsor
- Sanguine Biosciences
CompletedNCT00205933
This study has finished and is no longer accepting participants.
Multiple locations, including BostonDepression, BipolarityObservational studyAges 18–64
- Countries
- United States
- Sponsor
- Affective Neuroscience Laboratory
TerminatedNCT06431386
What is this study about?This study assesses depression symptoms.
This study ended early.
In OttawaDepression, BipolarityMedication studyAges 18–65
- Countries
- Canada
- Sponsor
- The Royal's Institute of Mental Health Research
CompletedNCT01329393
This study has finished and is no longer accepting participants.
In HartfordSchizophrenia, BipolarityBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Yale University
CompletedNCT00914680
Official study titleInvestigation of Efficacy and Tolerability of Magnetic Seizure Therapy in the Treatment of Depression
This study has finished and is no longer accepting participants.
In BerlinDepression, BipolarityInterventional studyAges 25–80
- Countries
- Germany
- Sponsor
- Charite University, Berlin, Germany
CompletedNCT01948024
Official study titleAn Open-label, Randomized, Two Treatment, Multi-site, Multiple Dose, Steady State, Three-way, Reference-replicated Crossover, Pharmacokinetic Study to Determine the In-vivo Bioequivalence Between Asenapine 10 mg Sublingual Tablet and SAPHRIS® (Asenapine) 10 mg Sublingual Tablet
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophrenia, BipolarityMedication studyAges 18–80
- Countries
- United States
- Sponsor
- Sun Pharmaceutical Industries Limited
CompletedNCT00601536
Official study titleA Single Dose, Two-Period, Two-Treatment Crossover Bioequivalency Study of 300 mg Lithium Carbonate Extended Release Tablets Under Fasting Conditions.
This study has finished and is no longer accepting participants.
In PittsburghBipolarityMedication studyAges 18–39
- Countries
- United States
- Sponsor
- Roxane Laboratories
CompletedNCT00602394
Official study titleA Single Dose, Two-Period, Two-Treatment Crossover Bioequivalency Study of 300 mg Lithium Carbonate Extended Release Tablets Under Fed Conditions
This study has finished and is no longer accepting participants.
In HoustonBipolarityMedication studyAges 18–38
- Countries
- United States
- Sponsor
- Roxane Laboratories
CompletedNCT00602381
Official study titleA Single Dose, Three-Treatment, Three-Period, Six-Sequence Crossover Bioequivalency Study of 450 mg Lithium Carbonate Extended Release Tablets Under Fasting Conditions
This study has finished and is no longer accepting participants.
In Little RockBipolarityMedication studyAges 25–45
- Countries
- United States
- Sponsor
- Roxane Laboratories
CompletedNCT00601575
Official study titleA Single Dose, Three-Treatment, Three-Period, Six-Sequence Crossover Bioequivalency Study of 450 mg Lithium Carbonate Extended Release Tablets Under Fed Conditions
This study has finished and is no longer accepting participants.
In Little RockBipolarityMedication studyAges 25–45
- Countries
- United States
- Sponsor
- Roxane Laboratories
CompletedNCT01976975
Official study titleMulti Level Analysis of Positive Valence Systems Across Mood Disorders
This study has finished and is no longer accepting participants.
In BelmontDepression, BipolarityObservational studyAges 18–50
- Countries
- United States
- Sponsor
- Mclean Hospital (Hospital / academic medical center)